Globus Medical (GMED) Tops Q4 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Globus Medical Reports Full Year and Fourth Quarter 2015 Results
February 24, 2016 4:50 PM ESTAUDUBON, Pa., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the fourth quarter and year ended December 31, 2015.
Fourth Quarter:
Worldwide sales increased 10.7% as reported to $142.6 million, or 11.5% on a constant currency basisFourth quarter net income was $37.6 millionEarnings per fully diluted share were $0.39Non-GAAP Adjusted EBITDA was 37.7% of salesFull Year 2015:
Worldwide sales increased 14.8% as reported to $544.8 million, or 16.0% on a constant currency basisNet income... More